Congenital Cardiac Anesthesia Society
A Section of the the Society for Pediatric Anesthesia

Congenital Cardiac Anesthesia Society

  • Member Login
  • Forgot Password?
  • Join
  • Home
  • About
    • Mission Statement
    • Bylaws
    • Board of Directors
    • History
    • Past Presidents
    • Charter Members
    • CCAS Lifetime Achievement Award
    • Mailing List Rental
    • Contact Us
  • Partners
    • SPA
    • SPPM
    • PALC
    • PCICS
    • AmSECT
    • SMACT
    • CHA
    • CCAN
  • Committees
    • CCAS Committees
      • Pediatric Cardiac Anesthesiology Program Director’s Group (PCAPD) Committee
      • Communications Committee
      • CCAS-STS Database Committee
      • Education Committee
      • Global Health Committee
      • Membership Committee
      • Quality and Safety Committee
      • Research Committee
    • CCAS Special Interest Groups
      • Adult Congenital Heart Disease Special Interest Group (SIG)
      • ERAS Special Interest Group (SIG)
      • Hemostasis Special Interest Group (SIG)
      • Latin America Special Interest Group (SIG)
      • Pulmonary Hypertension Special Interest Group (SIG)
      • Trainee Special Interest Group (SIG)
  • Membership
    • Benefits of Membership
    • CCAS Member App
    • Membership Categories
    • Join CCAS
      • Online Application
      • Printable Application
    • Renew Your Dues
    • Sponsor a Member
    • Get Involved
  • Meetings
    • Upcoming Meetings
    • Past Meetings
    • Other Meetings
    • Exhibit Information
  • Education
    • CCAS Virtual Visiting Professor Program
    • CCAS Webinar Series
      • CCAS Webinar Series – Recordings
    • CCAS COVID 19 Webinar
    • ACHD-SIG Anesthesia Rounds
    • Lecture Series
    • Echo Tutorial
    • Archived Questions
    • Poll of the Month Archives
    • Review Articles
      • CCAS-CHiP Network Journal Watch Collaboration
      • SCVA Articles
    • Journals of Interest
    • Books of Interest
    • Educational Links
  • Resources
    • CCAS Position Statements
    • CCAS Committee Resources
    • CCAS Special Interest Group (SIG) Resources
    • CCAS Cognitive Aids
    • Newsletters
    • Research Resources
    • Mission Trips
    • Societies
    • Job Opportunities
  • Research
    • Research Committee
    • CCAS 2025 Meeting Scholarship for Students and Residents
    • Research Network & Collaborative Opportunities
    • Research Resources
    • Dolly D. Hansen, MD Research Award
    • New for 2026! CCAS QI/Education Award
    • Podcast Series for Aspiring CCAS Researchers
    • Highlight on a CCAS Researcher
    • Call for Surveys
    • STS-CCAS Database
    • Donate to the Dolly Hansen Fund
  • Trainees
    • Introduction to Pediatric Cardiac Anesthesiology
    • Trainee Lecture Series
    • Advanced Training
    • Pediatric Cardiac Anesthesiology Fellowship Common Goals and Objectives
    • Frequently Asked Questions
    • Pediatric Cardiac Anesthesia Education Resources
    • Coaching/Mentoring Initiative
  • Patients
    • FAQs for Cardiac Anesthesia
    • FAQs for Cardiac Anesthesia – Spanish
    • SmartTots FAQs for Parents
    • Useful Resources for Parents

Question of the Week 528

Authors: Omar El Masri, MD, MA - Stanford University AND Kaitlin M. Flannery, MD, MPH - Stanford University


A 5-day-old, 3.2kg, term neonate with severe aortic coarctation and hypoplastic transverse arch (Z-score = -4) is currently managed on a PGE1 infusion with low lactate and good lower extremity pulses. According to the 2024 Society of Thoracic Surgeons (STS) Clinical Practice Guidelines on the management of neonates and infants with coarctation which is the MOST appropriate next step in management?

Correct! Wrong!

EXPLANATION


Coarctation of the aorta accounts for 4-5% of congenital heart disease (CHD). It is the second most common CHD requiring neonatal intervention after patent ductus arteriosus (PDA). In the current era, mortality following surgical repair is low at 0.98%. However, important short and long-term morbidity requiring repeat intervention persists, including re-coarctation and hypertension.1, 2


Despite the frequency of coarctation, management plans remain heterogenous among institutions and surgeons. In 2024, the STS published practice guidelines for the management of neonates and infants with coarctation of the aorta. Experts in the field reviewed the available literature and using a modified Delphi method established guidelines with classification of the recommendations and level of evidence.1


The following are the practice guidelines for neonates and infants with isolated coarctation1:


1. Surgical intervention is recommended in the absence of obvious contraindications. (Class I)
2. In patients with prematurity, low weight, or other risk factors for surgical intervention, medical optimization before intervention or primary operation is reasonable. (Class IIa)
3. In patients without associated arch hypoplasia, repair through a thoracotomy is indicated. (Class I)
4. In patients with associated arch hypoplasia that cannot be adequately addressed through a thoracotomy, repair through a sternotomy is preferable. (Class IIa)
5. In patients with bovine arch anatomy, repair through a sternotomy may be reasonable given the potential increased risk of re-coarctation with bovine arch anatomy repaired through a thoracotomy. (Class IIb)
6. In patients undergoing repair through a sternotomy, antegrade cerebral perfusions or limited duration deep hypothermic circulatory arrest may be reasonable. (Class IIb)
7. In patients undergoing repair through a sternotomy, extended end-to-end, arch advancement, and patch augmentation are all reasonable techniques. (Class IIa)


The patient presented above has no contraindications to surgical intervention and should undergo surgical repair before onset of complications. Given the patient’s significant transverse arch hypoplasia with a Z-score of -4, a sternotomy with repair on CPB is preferable as the risk of re-coarctation would be high with thoracotomy and repair that did not address the hypoplastic transverse arch.


The decision to perform arch repair on CPB with antegrade cerebral perfusion versus coarctation repair via thoracotomy without CPB significantly changes the anesthetic management and postoperative course. However, the literature review to produce these clinical practice guidelines found no significant difference in mortality, global neurologic outcomes, recurrent laryngeal nerve injury, or incidence of chylothorax between the two approaches.1,3


REFERENCES


1. Stephens EH, Feins EN, Karamlou T, et al. The Society of Thoracic Surgeons Clinical Practice Guidelines on the Management of Neonates and Infants with Coarctation.Ann Thorac Surg. 2024 Sep;118(3):527-44.


2. Spaeth JP, Loepke AW. Chapter 22: Anesthesia for left-sided obstructive lesions. In: Andropoulos DB, Stayer S, Mossad EB, Miller-Hance WC, eds. Anesthesia for Congenital Heart Disease. 3rd ed. Wiley Blackwell; 2015: 506-9.


3. Waldman JC, Ing RJ, Stone ML. Current Practice Management Guidelines in Neonates and Infants with Isolated Coarctation of the aorta. J Cardiothorac Vasc Anesth. 2025 Mar;39(3):573-5.

Poll of the Month

June 2025
At your institution, do patients presenting for elective cardiac surgery who are found to be anemic on routine testing undergo formal preoperative anemia testing and treatment?
View Results
Total Answers 20
Total Votes 20

Upcoming Meeting Information


CCAS 2026 Annual Meeting

March 12, 2026
Sheraton Denver Downtown
Denver, CO

 

 

 

 

Join CCAS
Renew
Donate
Get Involved
Upcoming
Job Postings
  • Member Login
  • Forgot Password?
2209 Dickens Road, Richmond, VA 23230 • 804-282-9780 • [email protected]
Copyright © 2025 The Congenital Cardiac Anesthesia Society | View Privacy Policy